• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从肾细胞癌和正常肾组织样本中纯化的微区室的蛋白质谱分析。

Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples.

作者信息

Raimondo F, Morosi L, Chinello C, Perego R, Bianchi C, Albo G, Ferrero S, Rocco F, Magni F, Pitto M

机构信息

Department of Experimental Medicine, University of Milano-Bicocca, Via Cadore 48, 20052 Monza, Italy.

出版信息

Mol Biosyst. 2012 Apr;8(4):1007-16. doi: 10.1039/c2mb05372a. Epub 2011 Dec 13.

DOI:10.1039/c2mb05372a
PMID:22159573
Abstract

Renal cell carcinoma (RCC) is representing about 3% of all adult cancers. A promising strategy for cancer biomarker discovery is subcellular comparative proteomics, allowing enriching specific cell compartments and assessing differences in protein expression patterns. We investigated the proteomic profile of a peculiar RCC subcellular compartment, plasma membrane microdomains (MD), involved in cell signalling, transport, proliferation and in many human diseases, such as cancer. Subcellular fractions were prepared by differential centrifugation from surgical samples of RCC and adjacent normal kidney (ANK). MD were isolated from plasma-membrane-enriched fractions after Triton X-100 treatment and sucrose density gradient ultracentrifugation. MD derived from RCC and ANK tissues were analyzed after SDS-PAGE separation by LC-ESI-MS/MS. We identified 93 proteins from MD isolated from RCC tissue, and 98 proteins from ANK MD. About 70% of the identified proteins are membrane-associated and about half of these are known as microdomain-associated. GRAVY scores assignment shows that most identified proteins (about 70%) are in the hydrophobic range. We chose a panel of proteins to validate their differential expression by WB. In conclusion, our work shows that RCC microdomain proteome is reproducibly different from ANK, and suggests that mining into such differences may support new biomarker discovery.

摘要

肾细胞癌(RCC)约占所有成人癌症的3%。癌症生物标志物发现的一个有前景的策略是亚细胞比较蛋白质组学,它可以富集特定的细胞区室并评估蛋白质表达模式的差异。我们研究了一种特殊的RCC亚细胞区室——质膜微结构域(MD)的蛋白质组概况,该结构域参与细胞信号传导、运输、增殖以及许多人类疾病,如癌症。通过差速离心从RCC手术样本和相邻正常肾组织(ANK)中制备亚细胞组分。经Triton X-100处理和蔗糖密度梯度超速离心后,从富含质膜的组分中分离出MD。通过LC-ESI-MS/MS对SDS-PAGE分离后的RCC和ANK组织来源的MD进行分析。我们从RCC组织分离的MD中鉴定出93种蛋白质,从ANK的MD中鉴定出98种蛋白质。约70%的已鉴定蛋白质与膜相关,其中约一半被认为与微结构域相关。GRAVY评分显示,大多数已鉴定蛋白质(约70%)处于疏水范围内。我们选择了一组蛋白质通过WB验证其差异表达。总之,我们的工作表明RCC微结构域蛋白质组与ANK有可重复的差异,并表明挖掘这些差异可能有助于发现新的生物标志物。

相似文献

1
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples.从肾细胞癌和正常肾组织样本中纯化的微区室的蛋白质谱分析。
Mol Biosyst. 2012 Apr;8(4):1007-16. doi: 10.1039/c2mb05372a. Epub 2011 Dec 13.
2
Differential protein profiling of renal cell carcinoma urinary exosomes.肾细胞癌尿液外泌体的差异蛋白质谱分析
Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.
3
Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.比较膜蛋白质组学:肾细胞癌生物标志物研究中的一项技术进展。
Mol Biosyst. 2015 Jun;11(6):1708-16. doi: 10.1039/c5mb00020c.
4
Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.肾细胞癌中的差异蛋白表达:通过质谱法发现新的生物标志物
J Proteome Res. 2009 Aug;8(8):3797-807. doi: 10.1021/pr800389e.
5
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE.透明细胞肾细胞癌的蛋白质组学分析:通过二维差异凝胶电泳鉴定差异表达蛋白
Mol Biosyst. 2012 Apr;8(4):1040-51. doi: 10.1039/c2mb05390j. Epub 2012 Feb 8.
6
Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.肾细胞癌临床样本中与化疗耐药、增殖及凋亡相关基因的表达及其与临床结局的相关性
Anticancer Res. 2002 Jan-Feb;22(1A):121-8.
7
Differential protein profiling in renal-cell carcinoma.肾细胞癌中的差异蛋白质谱分析。
Mol Carcinog. 2004 May;40(1):47-61. doi: 10.1002/mc.20015.
8
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.源自正常肾脏和肾细胞癌的原代细胞培养物保留了相应组织的蛋白质组学特征。
J Proteome Res. 2005 Sep-Oct;4(5):1503-10. doi: 10.1021/pr050002o.
9
Differential expression of AQP1 in microdomain-enriched membranes of renal cell carcinoma.AQP1 在肾透明细胞癌微域富集膜中的差异表达。
Proteomics Clin Appl. 2007 Jun;1(6):588-97. doi: 10.1002/prca.200601048. Epub 2007 May 11.
10
Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.透明细胞肾细胞癌的蛋白质组学分析。潜在肿瘤标志物的鉴定。
Saudi Med J. 2010 May;31(5):525-32.

引用本文的文献

1
Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms.采用全蛋白质法的绝对定量蛋白质组学鉴定肾肿瘤中新型临床免疫组织化学标志物。
BMC Med. 2021 Sep 6;19(1):196. doi: 10.1186/s12916-021-02071-9.
2
Proteomic approaches for characterizing renal cell carcinoma.用于表征肾细胞癌的蛋白质组学方法。
Clin Proteomics. 2020 Jul 29;17:28. doi: 10.1186/s12014-020-09291-w. eCollection 2020.
3
The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.
葡萄糖和脂质代谢重编程在肾透明细胞癌原代培养物中呈分级依赖性,并且可通过靶向调节来影响细胞活力和增殖。
Oncotarget. 2017 Dec 8;8(69):113502-113515. doi: 10.18632/oncotarget.23056. eCollection 2017 Dec 26.
4
Downregulation of ATP1A1 promotes cancer development in renal cell carcinoma.ATP1A1的下调促进肾细胞癌的癌症发展。
Clin Proteomics. 2017 May 4;14:15. doi: 10.1186/s12014-017-9150-4. eCollection 2017.
5
Development of a test to identify bladder cancer in the urine of patients using mass spectroscopy and subcellular localization of the detected proteins.开发一种利用质谱法和检测到的蛋白质的亚细胞定位来识别患者尿液中膀胱癌的检测方法。
Am J Transl Res. 2015 Aug 15;7(8):1458-66. eCollection 2015.
6
Coupling enrichment methods with proteomics for understanding and treating disease.将富集方法与蛋白质组学相结合以了解和治疗疾病。
Proteomics Clin Appl. 2015 Feb;9(1-2):33-47. doi: 10.1002/prca.201400097. Epub 2015 Jan 19.